SANDOZ INC.

Sandoz Inc. specializes in the manufacturing of pharmaceutical preparations, with a focused expertise in generic and branded drug products including hematology-related therapeutics, antibiotics such as amoxicillin-clavulanate, and diuretics like bumetanide. The company delivers end-to-end pharmaceutical production capabilities aligned with FDA and federal supply chain standards, ensuring consistent quality, regulatory compliance, and reliable supply of critical medications. Their technical proficiency includes formulation development, batch manufacturing, and lifecycle management of complex dosage forms, with demonstrated commitment to subcontracting compliance and small business engagement through structured, annually updated subcontracting plans integrated into federal contracts. Sandoz maintains a sustained and exclusive relationship with the Department of Veterans Affairs, serving as a trusted supplier of essential pharmaceuticals for veteran healthcare systems. Their work with VA centers on fulfilling long-term supply needs for high-volume, mission-critical drugs, often through Federal Supply Schedule contracts, with consistent contract modifications reflecting ongoing operational integration and compliance updates. This recurring engagement underscores a deep alignment with VA’s pharmaceutical procurement priorities and a proven ability to meet stringent federal distribution and inventory requirements. The company operates primarily under NAICS 325412, which encompasses the manufacturing of finished pharmaceutical products, including tablets, capsules, and injectables. Sandoz positions itself as a reliable manufacturer of generic medications within the federal healthcare market, supporting public health initiatives through cost-effective, high-quality drug production. Their market focus is firmly on essential therapeutics used in chronic disease management, infection control, and specialty care. Sandoz Inc. is structured as a 2L entity headquartered in Princeton, New Jersey, with no disclosed government certifications. The company’s geographic presence is centered in the U.S., with operations tailored to meet federal pharmaceutical supply chain demands. Their business model emphasizes regulatory adherence, supply continuity, and contractual compliance within the federal healthcare procurement ecosystem.